Express Scripts ESRX 2016 Short Seller Report

A bear-case analysis of Express Scripts arguing for a $25/share price target, representing 67% downside from the April 2016 market price of $74.93. The report challenges consensus valuations across multiple metrics including P/E, EV/EBITDA, and free cash flow multiples.